Insider Transactions in Q4 2020 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2020
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.18%
|
$180,000
$6.32 P/Share
|
|
Oct 08
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
24,260
-0.67%
|
$1,213,000
$50.97 P/Share
|
|
Oct 08
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
24,260
+1.33%
|
$0
$0.33 P/Share
|
|
Oct 07
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
50,000
-1.37%
|
$2,450,000
$49.8 P/Share
|
|
Oct 07
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+2.66%
|
$0
$0.33 P/Share
|
|
Oct 06
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
18,280
-0.51%
|
$895,720
$49.41 P/Share
|
|
Oct 06
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
18,280
+1.01%
|
$0
$0.33 P/Share
|
|
Oct 06
2020
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,250
-83.89%
|
$306,250
$49.37 P/Share
|
|
Oct 06
2020
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$43,750
$7.8 P/Share
|
|
Oct 01
2020
|
Eric Dobmeier Director |
SELL
Open market or private sale
|
Direct |
10,000
-96.12%
|
$480,000
$48.84 P/Share
|
|
Oct 01
2020
|
Eric Dobmeier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.32 P/Share
|
|
Oct 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
6,771
-93.41%
|
$325,008
$48.86 P/Share
|
|
Oct 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
6,771
+34.03%
|
$40,626
$6.79 P/Share
|
|
Oct 01
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
600
-0.03%
|
$30,000
$50.05 P/Share
|
|
Oct 01
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+0.03%
|
$0
$0.33 P/Share
|
|
Oct 01
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
14,725
-100.0%
|
$721,525
$49.0 P/Share
|
|
Oct 01
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,725
+50.0%
|
$0
$0.84 P/Share
|